Aromatase inhibitor-associated musculoskeletal syndrome: understanding mechanisms and management

T Hyder, CC Marino, S Ahmad… - Frontiers in …, 2021 - frontiersin.org
Aromatase inhibitors (AIs) are a key component in the chemoprevention and treatment of
hormone receptor-positive (HR+) breast cancer. While the addition of AI therapy has …

[HTML][HTML] Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer

M Gnant, F Fitzal, G Rinnerthaler… - … England Journal of …, 2021 - Mass Medical Soc
Background For postmenopausal women with hormone-receptor–positive breast cancer, the
most effective duration for adjuvant therapy with an aromatase inhibitor remains unclear …

[HTML][HTML] Preventing late recurrence in hormone receptor-positive early breast cancer: a review

NML Battisti, IE Smith - European Journal of Cancer, 2022 - Elsevier
Late recurrences are a key challenge for patients with early-stage oestrogen receptor-
positive breast cancer, with the risk of disease relapse continuing steadily from 5 to more …

[HTML][HTML] Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and …

G Jerusalem, S Farah, A Courtois, J Chirgwin, S Aebi… - Annals of oncology, 2021 - Elsevier
Background Late recurrences in postmenopausal women with hormone receptor-positive
breast cancers remain an important challenge. Avoidance or delayed development of …

Intermittent Use of Anti-Hormonal Agents for the Endocrine Therapy of Sex-Hormone-Dependent Breast and Prostate Cancer: A Protocol for a Systematic Review

D Kesztyüs, J Kämpfer, T Kesztyüs - International Journal of …, 2022 - mdpi.com
Therapies with the continuous administration of anti-hormonal agents in sex-hormone-
dependent malignancies such as prostate and breast carcinomas often lead to the …

[HTML][HTML] LIQUILETRO 3.5 MG/ML| 60ML SKU PN-LETRO-60 Rating: 96% of 100

CS Cost - pinnaclepeptides.com
Buy Letrozole Online | Purchase Liquid Letro for Sale The store will not work correctly when
cookies are disabled. Skip to Content Wishlist Sign In Create an Account Toggle Nav main …

Adjuvant endocrine and targeted therapy for postmenopausal women with hormone receptor-positive breast cancer

KI Pritchard - uptodate.com
Breast cancer is the most frequently diagnosed cancer and the leading cause of death from
cancer in women worldwide. Breast cancer is a heterogeneous, phenotypically diverse …